Polycythemia vera is a rare form of blood cancer. Learn more about the symptoms, causes, complications, diagnosis, treatment, prognosis, and life expectancy related to polycythemia vera.
Polycythemia Vera Myelofibrosis. Tools Resources. Thyroid Test Antithyroid drugs; Arsenicals; Barbiturates; Diuretics Sulfonamides
Polycythemia, also called erythrocytosis, refers to increased red blood cell mass, noted on laboratory evaluation as increased hemoglobin and hematocrit levels. Polycythemia vera is a subtype of polycythemia and can be associated with the overproduction of more than just the erythrocytic lineage.
Primary polycythemia, or polycythemia vera, is due to a recurrent Performance-enhancing/steroidal drugs. Smoking. Obstructive sleep
Polycythemia is a condition marked by an abnormally large number of red blood cells in the circulatory system. Topics under Polycythemia. Polycythemia Vera
drug that targets the JAK2 mutation. Clinical trials for people with polycythemia vera using new drugs are currently ongoing. Some people with polycythemia
Polycythemia vera and noncirrhotic portal hypertension diagnosed during Drugs: adverse reactions Drugs: antimicrobials Drugs: cardiovascular system.
Polycythemia vera. In subject area: Medicine and Dentistry. Currently, polycythemia vera is defined as an acquired multipotential hematopoietic stem cell defect
Currently, the drug is in the Phase III stage of its development for the treatment of Polycythemia Vera. AMX0035: Amylyx Pharmaceuticals.
Comments